Development of a Neurocognitive Screening Test

Status

Terminated

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT02597504

Enrollment

1600

Registered

2015-11-05

Start date

2015-10-31

Completion date

2019-10-31

Last updated

2023-09-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Brain Concussion, Mild Cognitive Impairment

Brief summary

This research study will evaluate a standalone software application and is designed to standardize and validate new neurocognitive screening testing for children aged 6 through 11, and adolescents and adults ages 12 through 75. The purpose of this study is to evaluate recently developed computerized tasks sensitive to changes in neurocognitive performance after a concussion. These tests were designed to help measure the effects of concussion on cognitive processes (e.g., memory, attention, brain speed) and visual functioning.

Interventions

OTHERPen and paper neuropsychological test

Will be administered for Construct Validity to determine agreement with Quick Test

DEVICEQuick Test

Quick Test, computerized test will be administered to all subjects.

Study design

Allocation

NON_RANDOMIZED

Intervention model

PARALLEL

Primary purpose

DIAGNOSTIC

Masking

NONE

Eligibility

Sex/Gender

ALL

Age

6 Years to 75 Years

Healthy volunteers

Yes

Inclusion criteria

* Age: 12-75 (Adult version), 6-11 (pediatric version) * Primary English speaking or fluent in English. * No known special education diagnosis excluding a 504 designation. * Currently not suffering from a concussion or being treated for a concussion.\* * No known physical or psychological impairment that would affect their ability to perform the test.

Exclusion criteria

* Documentation of a known special education diagnosis other than a 504 designation. * English is not their primary language nor are they proficient in the English language. * Currently suffering from a concussion or being treated for a concussion.\* * Any known physical or psychological impairment that would affect their ability to perform the test. * Note: Unless specifically required by the particular study (i.e., a discriminant validity study differentiating concussed versus non-concussed individuals).

Design outcomes

Primary

Measure	Time frame
Reliability will be established through a test-retest to establish results should be stable over time	12 Months
Validity established through correlation studies with well-known measures of memory and processing speed and ANOVA.	12 Months

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026